Estimating the age of p.(Phe508del) with family studies of geographically distinct European populations and the early spread of cystic fibrosis

European Journal of Human Genetics

Volumn 26, Issue 12, 2018, Pages 1832-1839

  Farrell, Philip ^a   Férec, Claude ^b,c   Macek, Milan ^d   Frischer, Thomas ^e   Renner, Sabine ^e   Riss, Katharina ^e   Barton, David ^f,g   Repetto, Teresa ^h   Tzetis, Maria ⁱ   Giteau, Karine ^c   Duno, Morten ^j   Rogers, Melissa ^f   Levy, Hara ^k   Sahbatou, Mourad ^l   Fichou, Yann ^b   Le Maréchal, Cédric ^b,c   Génin, Emmanuelle ^b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITÉ DE BRETAGNE OCCIDENTALE   (France)

^c BREST UNIVERSITY HOSPITAL   (France)

^d UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^e UNIV KLIN KINDER JUGENDHEILKUNDE   (Austria)

^f UNIVERSITY COLLEGE DUBLIN   (Ireland)

^g OUR LADY S CHILDREN S HOSPITAL   (Ireland)

^h UNIVERSITY OF FLORENCE   (Italy)

ⁱ UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^j Mental Health Center Glostrup   (Denmark)

^k NORTHWESTERN UNIVERSITY   (United States)

^l FONDATION JEAN DAUSSET CEPH   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; MICROSATELLITE DNA; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR DELTA F508;

AGE DETERMINATION; ARTICLE; BRONZE AGE; CYSTIC FIBROSIS; DNA SEQUENCE; EUROPEAN; FAMILY STUDY; GENE FREQUENCY; GENETIC VARIABILITY; HAPLOTYPE; HETEROZYGOSITY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MIGRATION; POPULATION GENETICS; PRIORITY JOURNAL; EUROPE; GENETICS; PEDIGREE; POPULATION;

CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; EUROPE; HUMAN MIGRATION; HUMANS; MICROSATELLITE REPEATS; PEDIGREE; POPULATION;

EID: 85052539396     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/s41431-018-0234-z     Document Type: Article

References (34)

1. Kerem B, Rommens JM, Buchanan JA, et al. Identification of the cystic fibrosis gene: genetic analysis. Science. 1989;245:1073–80
2. Bobadilla JL, Macek Jr M, Fine JP, Farrell PM. Cystic fibrosis: a worldwide analysis of CFTR mutations-correlation with incidence data and application to screening. Hum Mutat. 2002;19:575–606
3. De Braekeleer M, Daigneault J. Spatial distribution of the DF508 mutation in cystic fibrosis: a review. Hum Biol. 1992;64:167–74
4. Lucotte G, Hazout S, De Braekeleer M. Complete map of cystic fibrosis mutation DF508 frequencies in western Europe and correlation between mutation frequencies an incidence of disease. Hum Biol. 1995;67:797–803
5. Farrell P, Le Marechal C, Ferec C, Siker M, Teschler-Nicola M. Discovery of the principal cystic fibrosis mutation (F508del) in ancient DNA from Iron Age Europeans. Nat Preced. 2007;1276:1 http://hdl.nature.com/10101/npre
6. Morral N, Bertranpetit J, Estivill X, et al. The origin of the major cystic fibrosis mutation (delta F508) in European populations. Nat Genet. 1994;7:169–75
7. Fichou Y, Génin E, Le Maréchal C, Audrézet MP, Scotet V, Férec C. Estimating the age of CFTR mutations predominantly found in Brittany (Western France). J Cyst Fibros. 2008;7:168–73
8. Strom CM, Strom CM, Crossley B, et al. Cystic fibrosis testing 8 years on: lessons learned from carrier screening and sequencing analysis. Genet Med. 2011;13:166–72
9. Castellani C, Massie J, Sontag M, Southern KW. Newborn screening for cystic fibrosis. Lancet Respir Med. 2016;4:653–61
10. Gregg RG, Wilfond BS, Farrell PM, Laxova A, Hassemer D, Mischler EH. The application of DNA analysis in a population screening program for neonatal diagnosis of cystic fibrosis: comparison of screening protocols. Am J Hum Genet. 1993;52:616–26
11. Serre JL, Simon-Bouy B, Mornet E, et al. Studies of RFLP closely linked to the cystic fibrosis locus throughout Europe lead to new considerations in population genetics. Hum Genet. 1990;84:449–54
12. Morral N, Nunes V, Casals T, et al. Microsatellite haplotypes for cystic fibrosis: mutation frameworks and evolutionary tracers. Hum Mol Genet. 1993;2:1015–22
13. Romeo G, Devoto M, Galietta LVJ. Why is the cystic fibrosis gene so frequent? Hum Genet. 1989;84:1–5
14. Rodman DM, Zamudio S. The cystic fibrosis heterozygote--advantage in surviving cholera? Med Hypotheses. 1991;36:253–8
15. Cuthbert AW, Halstead J, Ratcliff R, Colledge WH, Evans MJ. The genetic advantage hypothesis in cystic fibrosis heterozygotes: a murine study. J Physiol. 1995;15:449–54
16. Piel FB, Patil AP, Howes RE, et al. Global distribution of the sickle cell gene and geographical confirmation of the malaria hypothesis. Nat Commun. 2010;1104:1–7
17. Bitoungui VJ, Pule GD, Hanchard N, Ngogang J, Wonkam A. Beta-globin gene haplotypes among cameroonians and review of the global distribution: is there a case for a single sickle mutation origin in Africa? OMICS. 2015;19:171–9
18. Pauling L, Itano HA, Singer SJ, Wells IC. Sickle cell anemia, a molecular disease. Science. 1949;110:543–8
19. Browning SR, Browning BL. Rapid and accurate haplotype phasing and missing data inference for whole genome association studies using localized haplotype clustering. Am J Hum Genet. 2007;81:1084–97
20. Génin E, Tullio-Pelet A, Lyonnet S, Abel L. Estimating the age of rare disease mutations: the example of Triple A syndrome. J Med Genet. 2004;41:445–9
21. Cunliffe B. Europe between the Oceans. New Haven: Yale University Press; 2008
22. Price TD. Europe before Rome. New York: Oxford University Press; 2013
23. Cordovado SK, Hendrix M, Greene CN, et al. CFTR mutation analysis and haplotype associations in DNA used for proficiency testing. Mol Genet Metab. 2012;105:249–54
24. Lao O, Lu TT, Nothnagel M, et al. Correlation between genetic and geographic structure in Europe. Curr Biol. 2008;18:1241–8
25. Heath SC, Gut IG, Brennan P, et al. Investigation of the fine structure of European populations with applications to disease association studies. Eur J Hum Genet. 2008;16:1413–29
26. Kaplan NL, Lewis PO, Weir BS. Age of the ΔF508 cystic fibrosis mutation. Nat Genet. 1994;8:216–7
27. Allentoft ME, Sikora M, Sjögren KG. et al. Population genomics of Bronze Age Eurasia. Nature. 2015;522:167–72
28. Müller J, van Willigen S. New radiocarbon evidence for European Bell Beakers and the consequences for the diffusion of the Bell Beaker phenomenon. In: Nicolis F, editors. Bell Beakers today. Pottery, people, culture, symbols in prehistoric Europe (Proceedings of the International Colloquium, Riva del Garda, Trento, Italy); 2001. pp. 59–80
29. Olalde S, Brace ME, Allentoft I, et al. The Beaker phenomenon and the genomic transformation of northwest Europe. Nature. 2018;555:190–6
30. Price TD, Knipper C, Grupe G, Smrcka V. Strontium isotopes and prehistoric human migration: the Bell Beaker period in central Europe. Eur J Archaeol. 2004;7:9–40
31. Needham S. Transforming Beaker culture in north-west Europe: processes of fusion and fission. Proc Prehist Soc. 2005;71:171–217
32. Farrell PM. The prevalence of cystic fibrosis in the European Union. J Cyst Fibros. 2008;7:450–3
33. Harrison RJ. The Beaker Folk: Copper Age archaeology in in Western Europe. London, UK: Thames and Hudson; 1980
34. Poolman EM, Galvani AP. Evaluating candidate agents of selective pressure for cystic fibrosis. J R Soc Interface. 2007;4:91–8